MetLife Investment Management’s Asensus Surgical, Inc. ASXC Stock Holding History

MetLife Investment Management’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-92,945	Closed	-$103K	–	2779
2021 Q4	$103K	Buy	92,945 +45,818	+97%	+$70.8K	﹤0.01%	2397
2021 Q3	$87.2K	Sell	47,127 -42,111	-47%	-$94.6K	﹤0.01%	2489
2021 Q2	$283K	Buy	+89,238	New	+$223K	﹤0.01%	1931
2019 Q3	–	Sell	-5,618	Closed	-$99.3K	–	2408
2019 Q2	$99.3K	Hold	5,618	–	–	﹤0.01%	2372
2019 Q1	$174K	Hold	5,618	–	–	﹤0.01%	2046
2018 Q4	$165K	Hold	5,618	–	–	﹤0.01%	2014
2018 Q3	$424K	Sell	5,618 -228	-4%	-$15.4K	﹤0.01%	1636
2018 Q2	$331K	Buy	+5,846	New	+$213K	﹤0.01%	1662

Other funds holding ASXC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MetLife Investment Management's ASXC Position: Q1 2022 in Review

MetLife Investment Management sold out of Asensus Surgical, Inc. (ASXC) in Q1 2022, closing a stake of 92,945 shares — an estimated $103K sold.

MetLife Investment Management first reported a position in ASXC in Q2 2018 and held it in 8 quarters. The position peaked at $424K in Q3 2018. 115 funds tracked by Wall St. Rank hold ASXC as of Q1 2022.

MetLife Investment Management reported no remaining Asensus Surgical, Inc. position as of Q1 2022 after selling out during the quarter.
MetLife Investment Management sold 92,945 Asensus Surgical, Inc. shares in Q1 2022, an estimated $103K.
MetLife Investment Management first reported a position in Asensus Surgical, Inc. in Q2 2018 and held it in 8 quarters.
MetLife Investment Management's Asensus Surgical, Inc. position peaked at $424K in Q3 2018.
115 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2022.

Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.